Hey everyone, with all of the scientific knowledge within the forum of NW Science I thought that I might be able to attain some insight.
The private Human Genome Project run by Celera was a company that everyone was under the impression would be a boom and a success. The compan is publicaly traded (CRA) and thus I looked into the trade prices / share and it was above $200.00 after the Wall Street Journal described their involvement in the Genome Project, and then the price fell out of the bottom of the stocks and stays low. Does anyone have an opinion about this? No "insider trading info" of course:)
Other biotech companies remain relatively weak in the market, I am a fan of biotech company investing but understand the risks. Currently with the change of government I am of the opinion that the stem cell companies with rise in stock.....any comments, opinions, concerns, complaints?
Lewer
Tags:
Share
Facebook
You need to be a member of MyNWscience to add comments!
Join MyNWscience